There are repeated indications that lymphatic dysfunction and loss of lymphatic VEGF-C signaling results in exacerbation of clinical findings of liver disease including portal hypertension and ascites (Kaur et al., 2021; Aboismail et al., 2022). The gene discussed is VEGFC; the disease is portal hypertension.